Reduction of C/EBPα gene expression occurred in hepatocellular carcinoma, skin carcinoma and lung cancer, in particular in lung adenocarcinomas, which had the most significant and frequent reduction in C/EBPα gene expression[4]. This evidence concerns the gene CEBPA and lung carcinoma.